期刊文献+

脂蛋白相关磷脂酶A2检测在老年心脑血管疾病防治中的临床意义 被引量:3

Clinical significance of Lp-PLA2 in prevention of cardiovascular and cerebrovascular diseases in elderly people
原文传递
导出
摘要 目的:探讨脂蛋白相关磷脂酶A2(Lp-PLA2)检测在老年心脑血管病防治的意义。方法:选取老年体检人群185例,收集资料包括血脂、血糖等生化指标,病史及一二级预防用药情况,采用酶联免疫吸附法(ELISA)检测血浆Lp-PLA2水平,6个月后电话随访有无确诊的心脑血管疾病事件发生情况。结果:血浆Lp-PLA2水平与总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)水平呈正相关,其相关系数分别为0.219(P=0.003)和0.185(P=0.012);与口服降脂药呈负相关,相关系数为-0.153(P=0.038)。随访6个月共有新发心脑血管疾病患者10例(6.7%),其中冠心病8例(5.3%),短暂性脑缺血发作1例(0.67%),脑梗死1例(0.67%)。Logistic回归模型显示,Lp-PLA2异常是唯一对心脑血管发生有影响的重要危险因素(P=0.046)。结论:Lp-PLA2异常与心脑血管疾病发生密切相关,在老年体检中开展Lp-PLA2检测有利于发现高危人群,对有效防治心脑血管疾病有重要意义。 Objective: To study the significance of the lipoprotein associated phospholipase A2( Lp-PLA2) in the prevention of cardiovascular and cerebrovascular diseases in elderly people. Methods: 185 elderly people were selected. The physical examination data such as blood lipid,blood glucose,medical history and both primary and secondary prevention medication were collected,and the plasma Lp-PLA2 level was determined with enzyme-linked immunosorbent assay( ELISA). After 6 months,the telephone follow-up was made to reveal the incidence of diagnosed cardiovascular and cerebrovascular diseases. Results: There was a positive correlation between plasma Lp-PLA2 level and total cholesterol( TC),low density lipoprotein cholesterol( LDL-C),the correlation coefficient being 0. 219( P = 0. 003) and 0. 185( P = 0. 012),respectively. There was a negative correlation between the plasma Lp-PLA2 level and the use of lipid-lowering drugs,while the correlation coefficient was 0. 153( P =0. 038). After a follow-up of 6 months,we found 10 new patients with cardiovascular and cerebrovascular diseases( 6. 7%). Eight of them were coronary heart diseases( 5. 3%). One of them was transient ischemic attack( 0. 67%). One of them was cerebral infarction( 0. 67%). A logistic regression model showed that abnormal LpPLA2 was the only important risk factor which influenced the incidence of cardiovascular and cerebrovascular diseases( P = 0. 046). Conclusion: The abnormal Lp-PLA2 is closely related with the incidence of cardiovascular and cerebrovascular diseases. It can help us screening people with high risk with Lp-PLA2 test in the elderly people health examination,and it has important significance for prevention and treatment in cardiovascular and cerebrovascular diseases.
出处 《现代医学》 2015年第6期761-764,共4页 Modern Medical Journal
关键词 脂蛋白相关磷脂酶A2 心脑血管疾病 老年 lipoprotein associated phospholipase A2 cardiovascular and cerebrovascular diseases elderly
  • 相关文献

参考文献10

二级参考文献44

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 2Garza CA, Montori VM, McConnell JP, et al. Association be tween lipoprotein-associated phospholipase A2 and cardiovas cular disease: A systematic review. Mayo Clin Proceedings 2007,82:159-165.
  • 3Oei H H, vander Meer IM, Hofman A, et al. Lipoprotein-associ ated phospholipase A2 activity is associated with risk of coro nary heart disease and ischemic stroke: the Rotterdam Study Circulation,2005,111:570-575.
  • 4Winkler K, Winkelmann BR, Scharnagl H, et al. Platelet acti vating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors;The Ludwigshafen Risk and Cardiovascular Health Study. Circulation, 2005,111 ; 980-987.
  • 5EIGLER N, PFAFF J M, WHITING J, et al. The role of digital angiography in the evaluation of coronary artery disease [ J ]. Int J Cardiol,1986,10 ( 1 ) :3-13.
  • 6ARONOW H D, QUINN M J, GURM H S, et al. Preprocedure inflammatory state predicts periprocedural myocardial infarction after elective percutaneous coronary intervention: an EPIC substudy[J]. Am J Cardiol,2003,41 (Suppl A) :17A.
  • 7DANESH J, WHEELER J G, HIRSCHFIELD G M, et al. C- reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [ J ]. N Engl J Med, 2004,350 (14) : 1387- 1397.
  • 8PASCERI V,WILLERSON J T,YEH E T. Direct proinflammatory effect of C-reactive protein on human endothelial cells [ J ]. Circulation,2000,102 (18) :2165-2168.
  • 9SOLYMOSS B C, BOURASSA M G, CAMPEAU L A, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity [J]. Am J Cardiol,2004,93 (2) :159-164.
  • 10Zalewski A, Macphee C. Role of lipoprotein-associated phosphotipaseA2 in atherosclerosis: biology, epidemiotogy, and possible therapeutic: target [J] . Arterioscler Thromb Vasc Biol, 2005, 25 (5) : 923-931.

共引文献75

同被引文献22

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部